Health
The world is hungry for mRNA COVID vaccines like Pfizer’s. But we’re short of vital components – Australian Times
Given the AstraZeneca COVID-19 vaccine is no longer recommended for under-50s following news of very rare blood clots, Australia is looking to other vaccines to…
Archa Fox, The University of Western Australia and Pall Thordarson, UNSW
Given the AstraZeneca COVID-19 vaccine is no longer recommended for under-50s following news of very rare blood clots, Australia is looking to other vaccines to plug the gap.
Pfizers mRNA vaccine will become the mainstay of the rollout, with 40 million doses expected to arrive before years end.
But Australia isnt the only country eager to get its hand on this vaccine.
Skyrocketing demand coupled with shortages of vital components…
-
Noosa News17 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business18 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Business22 hours agoDividends from ASX 200 bank shares ‘looking very stretched’: expert
-
Noosa News22 hours agoMan who allegedly stole children’s underwear charged with 28 offences